Neurologic conditions are difficult to treat. Clearinghouse, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5023. NLM AIDSLINE Important note: Information in this article was accurate in 1995. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


Neurologic conditions are difficult to treat. Clearinghouse, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5023.

GMHC Treat Issues. 1995 Mar;9(3):8-11. Unique Identifier : AIDSLINE AIDS/95700413
van Baelen G


Abstract: The Multicenter AIDS Cohort Study concluded that HIV-related sensory neuropathy and four opportunistic central nervous system diseases showed a significant upward trend in incidence between 1985 and 1992. Early, aggressive treatment is often necessary for neurological conditions, since mortality and irreversible damage rates can be very high for untreated individuals. Six conditions are presented, showing treatment difficulties of both symptoms, and the underlying disease process. These conditions cover opportunistic infections (toxoplasmosis encephalitis, cryptococcal meningitis, and progressive multifocal leukoencephalopathy), malignancy (primary CNS lymphoma), cognitive disorder (AIDS dementia complex), and nerve damage (peripheral neuropathies).
Keywords: Antineoplastic Agents/THERAPEUTIC USE AIDS Dementia Complex/DRUG THERAPY AIDS-Related Opportunistic Infections/COMPLICATIONS/*DRUG THERAPY Central Nervous System Neoplasms/COMPLICATIONS/DRUG THERAPY Cohort Studies Drug Therapy, Combination Encephalitis/COMPLICATIONS/DIAGNOSIS/DRUG THERAPY Human Leukoencephalopathy, Progressive Multifocal/COMPLICATIONS/DRUG THERAPY Lymphoma/COMPLICATIONS/DRUG THERAPY Meningitis, Cryptococcal/COMPLICATIONS/DRUG THERAPY Nervous System Diseases/COMPLICATIONS/*DRUG THERAPY Peripheral Nervous System Diseases/COMPLICATIONS/DRUG THERAPY Toxoplasmosis/COMPLICATIONS/DIAGNOSIS/DRUG THERAPY NEWSLETTER ARTICLE

KWDantineoplasticagents/therapeuticuseaidsdementiacomplex/drugtherapyaids-relatedopportunisticinfections/complications/
951130
M95B0880


Copyright © 1995 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1995. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1995. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .